Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Treatment of oncogene-addicted non-small cell lung cancer (NSCLC) has been changed by the advent of tyrosine kinase inhibitors (TKIs). Albeit great benefits are achieved with target therapies, resistance invariably occurs and recourse to alternative treatments is unavoidable. Immune chec...

Descripción completa

Detalles Bibliográficos
Autores principales: Guaitoli, Giorgia, Tiseo, Marcello, Di Maio, Massimo, Friboulet, Luc, Facchinetti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article on Immunotherapy in Other Thoracic Malignancies and Uncommon Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264334/
https://www.ncbi.nlm.nih.gov/pubmed/34295687
http://dx.doi.org/10.21037/tlcr-20-941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264334/
https://www.ncbi.nlm.nih.gov/pubmed/34295687
http://dx.doi.org/10.21037/tlcr-20-941

Ejemplares similares